These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10882565)

  • 1. Modeling the interaction of peroxynitrite with low-density lipoproteins. II: reaction/diffusion model of peroxynitrite in low-density lipoprotein particles.
    Stanbro WD
    J Theor Biol; 2000 Aug; 205(3):465-71. PubMed ID: 10882565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the interaction of peroxynitrite with low-density lipoproteins. I. Plasma levels of peroxynitrite.
    Stanbro WD
    J Theor Biol; 2000 Aug; 205(3):457-64. PubMed ID: 10882564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the interaction of peroxynitrite with low-density lipoproteins. III: the role of antioxidants.
    Stanbro WD
    J Theor Biol; 2000 Aug; 205(3):473-82. PubMed ID: 10882566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinetic model of the system: tyrosyl radical-nitrogen oxide-superoxide ion.
    Stanbro WD
    J Theor Biol; 1999 Apr; 197(4):557-67. PubMed ID: 10196097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical-initiated lipid peroxidation in low density lipoproteins: insights obtained from kinetic modeling.
    Waldeck AR; Stocker R
    Chem Res Toxicol; 1996 Sep; 9(6):954-64. PubMed ID: 8870982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of peroxynitrite with carotenoids in human low density lipoproteins.
    Panasenko OM; Sharov VS; Briviba K; Sies H
    Arch Biochem Biophys; 2000 Jan; 373(1):302-5. PubMed ID: 10620353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights.
    Rubbo H; O'Donnell V
    Toxicology; 2005 Mar; 208(2):305-17. PubMed ID: 15691594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of nitric oxide and peroxynitrite with low-density lipoprotein.
    Rubbo H; Trostchansky A; Botti H; Batthyány C
    Biol Chem; 2002; 383(3-4):547-52. PubMed ID: 12033442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of lipid-protein adducts in low-density lipoprotein by fluxes of peroxynitrite and its inhibition by nitric oxide.
    Trostchansky A; Batthyány C; Botti H; Radi R; Denicola A; Rubbo H
    Arch Biochem Biophys; 2001 Nov; 395(2):225-32. PubMed ID: 11697860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of peroxynitrite and nitric oxide with LDL.
    Botti H; Trostchansky A; Batthyány C; Rubbo H
    IUBMB Life; 2005 Jun; 57(6):407-12. PubMed ID: 16012049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of peroxynitrite with carotenoids and tocopherols within low density lipoprotein.
    Pannala AS; Rice-Evans C; Sampson J; Singh S
    FEBS Lett; 1998 Feb; 423(3):297-301. PubMed ID: 9515727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.
    Spiteller G
    Mol Nutr Food Res; 2005 Nov; 49(11):999-1013. PubMed ID: 16270286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the alpha,beta-unsaturated keto functionality of 2'-hydroxychalcones as a novel antioxidant pharmacophore.
    Stevens JF; Miranda CL; Frei B; Buhler DR
    Chem Res Toxicol; 2003 Oct; 16(10):1277-86. PubMed ID: 14565769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative modification of low density lipoprotein and its relation to atherosclerosis.
    Aviram M
    Isr J Med Sci; 1995 Apr; 31(4):241-9. PubMed ID: 7721566
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenolic antioxidants and the protection of low density lipoprotein from peroxynitrite-mediated oxidations at physiologic CO2.
    Ferroni F; Maccaglia A; Pietraforte D; Turco L; Minetti M
    J Agric Food Chem; 2004 May; 52(10):2866-74. PubMed ID: 15137827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for thermal stability of human low-density lipoprotein.
    Jayaraman S; Gantz D; Gursky O
    Biochemistry; 2005 Mar; 44(10):3965-71. PubMed ID: 15751972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the antioxidant to pro-oxidant switch in the behavior of dehydroascorbate during LDL oxidation by copper(II) ions.
    Horsley ET; Burkitt MJ; Jones CM; Patterson RA; Harris LK; Moss NJ; del Rio JD; Leake DS
    Arch Biochem Biophys; 2007 Sep; 465(2):303-14. PubMed ID: 17689484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.